Phase I and biomarker study of ABT-869, a multiple receptor tyrosine kinase inhibitor, in patients with refractory solid malignancies.
| Autor: | Wong CI, Koh TS, Soo R, Hartono S, Thng CH, McKeegan E, Yong WP, Chen CS, Lee SC, Wong J, Lim R, Sukri N, Lim SE, Ong AB, Steinberg J, Gupta N, Pradhan R, Humerickhouse R, Goh BC, Wong, Chiung-Ing |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 10/1/2009, Vol. 27 Issue 28, p4718-4726, 9p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|